Oncolytic virotherapy with chimeric rVSV-NDV causes tumor-specific immunity in a DC-activation-dependent manner

Molecular Therapy: Oncology · Elsevier

Аннотация

Publication date: 17 September 2026 Source: Molecular Therapy Oncology, Volume 34, Issue 3 Author(s): Lorenz Hanesch, Nina Hartmann, Sonja Glauß, Tianle Feng, Jennifer Altomonte

Читать у издателя →

Похожие статьи